Decheng Capital Management III (Cayman), LLC - CHECKMATE PHARMACEUTICALS IN ownership

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Decheng Capital Management III (Cayman), LLC ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$4,253,0001,333,2541.30%
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders